249 related articles for article (PubMed ID: 19737925)
21. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
[TBL] [Abstract][Full Text] [Related]
22. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
[TBL] [Abstract][Full Text] [Related]
23. Regulation of hepatic cardiolipin metabolism by TNFα: Implication in cancer cachexia.
Peyta L; Jarnouen K; Pinault M; Coulouarn C; Guimaraes C; Goupille C; de Barros JP; Chevalier S; Dumas JF; Maillot F; Hatch GM; Loyer P; Servais S
Biochim Biophys Acta; 2015 Nov; 1851(11):1490-500. PubMed ID: 26327596
[TBL] [Abstract][Full Text] [Related]
24. A mouse model of short-term, diet-induced fatty liver with abnormal cardiolipin remodeling via downregulated Tafazzin gene expression.
Sakurai T; Chen Z; Yamahata A; Hayasaka T; Satoh H; Sekiguchi H; Chiba H; Hui SP
J Sci Food Agric; 2021 Sep; 101(12):4995-5001. PubMed ID: 33543498
[TBL] [Abstract][Full Text] [Related]
25. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
[TBL] [Abstract][Full Text] [Related]
26. Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
Kimura T; Kimura AK; Ren M; Berno B; Xu Y; Schlame M; Epand RM
Biochemistry; 2018 Apr; 57(14):2162-2175. PubMed ID: 29557170
[TBL] [Abstract][Full Text] [Related]
27. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.
Valianpour F; Mitsakos V; Schlemmer D; Towbin JA; Taylor JM; Ekert PG; Thorburn DR; Munnich A; Wanders RJ; Barth PG; Vaz FM
J Lipid Res; 2005 Jun; 46(6):1182-95. PubMed ID: 15805542
[TBL] [Abstract][Full Text] [Related]
28. Monolysocardiolipin: improved preparation with high yield.
Kim J; Hoppel CL
J Lipid Res; 2011 Feb; 52(2):389-92. PubMed ID: 20959418
[TBL] [Abstract][Full Text] [Related]
29. Cardiolipin remodeling in diabetic heart.
He Q; Han X
Chem Phys Lipids; 2014 Apr; 179():75-81. PubMed ID: 24189589
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cardiac mitochondrial monolysocardiolipin acyltransferase activity and expression during development and in fetal alcohol syndrome.
Taylor WA; Legare D; Lautt WW; Hatch GM
Proc West Pharmacol Soc; 2007; 50():115-8. PubMed ID: 18605246
[TBL] [Abstract][Full Text] [Related]
32. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.
Garlid AO; Schaffer CT; Kim J; Bhatt H; Guevara-Gonzalez V; Ping P
Gene; 2020 Feb; 726():144148. PubMed ID: 31647997
[TBL] [Abstract][Full Text] [Related]
33. Cardiolipin remodeling in a Chinese hamster lung fibroblast cell line deficient in oxidative energy production.
Rusnak A; Mangat R; Xu F; McClarty G; Hatch GM
J Bioenerg Biomembr; 1997 Jun; 29(3):291-8. PubMed ID: 9298714
[TBL] [Abstract][Full Text] [Related]
34. Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells.
Van Q; Liu J; Lu B; Feingold KR; Shi Y; Lee RM; Hatch GM
Biochem J; 2007 Jan; 401(1):103-9. PubMed ID: 16939411
[TBL] [Abstract][Full Text] [Related]
35. The influence of the acyl chain composition of cardiolipin on the stability of mitochondrial complexes; an unexpected effect of cardiolipin in alpha-ketoglutarate dehydrogenase and prohibitin complexes.
van Gestel RA; Rijken PJ; Surinova S; O'Flaherty M; Heck AJ; Killian JA; de Kroon AI; Slijper M
J Proteomics; 2010 Feb; 73(4):806-14. PubMed ID: 19944197
[TBL] [Abstract][Full Text] [Related]
36. Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV.
Corey RA; Harrison N; Stansfeld PJ; Sansom MSP; Duncan AL
Chem Sci; 2022 Nov; 13(45):13489-13498. PubMed ID: 36507170
[TBL] [Abstract][Full Text] [Related]
37. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
[TBL] [Abstract][Full Text] [Related]
38. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
39. N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics.
Chan JZ; Fernandes MF; Steckel KE; Bradley RM; Hashemi A; Groh MR; Sciaini G; Stark KD; Duncan RE
Sci Rep; 2022 Jun; 12(1):9466. PubMed ID: 35676289
[TBL] [Abstract][Full Text] [Related]
40. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria.
Schlame M; Rüstow B
Biochem J; 1990 Dec; 272(3):589-95. PubMed ID: 2268287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
